Seizure protein 6 controls glycosylation and trafficking of kainate receptor subunits GluK2 and GluK3.
Saved in:
| Title: | Seizure protein 6 controls glycosylation and trafficking of kainate receptor subunits GluK2 and GluK3. |
|---|---|
| Authors: | Pigoni M; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Neuroproteomics, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Hsia HE; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Neuroproteomics, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Hartmann J; UK Dementia Research Institute at UCL, University College London, London, UK., Rudan Njavro J; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Neuroproteomics, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Shmueli MD; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Neuroproteomics, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel., Müller SA; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Neuroproteomics, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Güner G; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Neuroproteomics, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Tüshaus J; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Neuroproteomics, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Kuhn PH; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Neuroproteomics, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Institut für Allgemeine Pathologie und Pathologische Anatomie, Technische Universität München, Munich, Germany., Kumar R; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Neuroproteomics, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Department of Neurology, Ludwig Maximilian University, Munich, Germany., Gao P; Department of Neurology, Ludwig Maximilian University, Munich, Germany.; Department of Translational Brain Research, German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Tran ML; Max Planck Institute of Biochemistry, Martinsried, Germany.; Department of Cell Biology, Yale University School of Medicine, New Haven, CT, USA., Ramazanov B; Department of Cell Biology, Yale University School of Medicine, New Haven, CT, USA., Blank B; Department of Cell Biology, Yale University School of Medicine, New Haven, CT, USA., Hipgrave Ederveen AL; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands., Von Blume J; Max Planck Institute of Biochemistry, Martinsried, Germany.; Department of Cell Biology, Yale University School of Medicine, New Haven, CT, USA., Mulle C; Interdisciplinary Institute for Neuroscience, University of Bordeaux, CNRS, UMR 5297, Bordeaux, France., Gunnersen JM; Department of Anatomy and Neuroscience, University of Melbourne, Melbourne, Vic., Australia.; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Vic., Australia., Wuhrer M; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands., Rammes G; Department of Anesthesiology and Intensive Care, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Busche MA; UK Dementia Research Institute at UCL, University College London, London, UK., Koeglsperger T; Department of Neurology, Ludwig Maximilian University, Munich, Germany.; Department of Translational Brain Research, German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Lichtenthaler SF; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Neuroproteomics, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Institute for Advanced Study, Technical University of Munich, Garching, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. |
| Source: | The EMBO journal [EMBO J] 2020 Aug 03; Vol. 39 (15), pp. e103457. Date of Electronic Publication: 2020 Jun 22. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8208664 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2075 (Electronic) Linking ISSN: 02614189 NLM ISO Abbreviation: EMBO J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1460-2075 |
|---|---|
| DOI: | 10.15252/embj.2019103457 |
